Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 643-654
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.643
Table 3 Pathological characteristics of patients according to perioperative red blood cell transfusion
Variable
Non-transfusion
Red blood cell transfusion
P value
n >= 529 (%)
n = 189 (%)
Tumor size (cm), mean ± SD4.3 ± 2.66.0 ± 3.6< 0.001
Tumor location0.039
    Lower327 (61.8)95 (50.3)
    Middle130 (24.6)60 (31.7)
    Upper64 (12.2)29 (15.3)
    Diffuse8 (1.5)5 (2.6)
Lauren histologic type10.002
    Intestinal276 (52.6)124 (66.0)
    Diffuse/mixed249 (47.4)64 (34.0)
Histological differentiation10.056
    Well/moderate 245 (46.7)103 (54.8)
    Poor 280 (53.3)85 (45.2)
Lymphatic invasion0.027
    No293 (55.4)87 (46.0)
    Yes236 (44.6)102 (54.0)
Vascular invasion0.017
    No364 (68.8)112 (59.3)
    Yes165 (31.2)77 (40.7)
Perineural invasion0.001
    No304 (57.5)83 (43.9)
    Yes225 (42.5)106 (56.1)
pT status < 0.001
    pT1/T2248 (46.9)54 (28.6)
    pT3/T4281 (53.1)135 (71.4)
Lymph nodes harvested, mean ± SD41.5 ± 19.439.2 ± 19.50.175
pN status 0.126
    pN0244 (46.1)75 (39.7)
    pN+285 (53.9)114 (60.3)
pTNM stage< 0.001
    I/II329 (62.2)86 (45.5)
    III/IV200 (37.8)103 (54.5)